<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03512912</url>
  </required_header>
  <id_info>
    <org_study_id>TESLA</org_study_id>
    <nct_id>NCT03512912</nct_id>
  </id_info>
  <brief_title>Transcutaneous Electrostimulation for Intermittent Claudication Supervised Walking Therapy for Intermittent cLAudication</brief_title>
  <acronym>TESLA</acronym>
  <official_title>Transcutaneous Electrostimulation of the Calf Muscle and Supervised Walking Therapy for Intermittent cLAudication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinrich-Heine University, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinrich-Heine University, Duesseldorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective mono-centric trial on patients with peripheral arterial disease and intermittent
      claudication that receive supervised exercise therapy (group 1) vs. supervised exercise
      therapy + daily transcutaneous electro-stimulation of the calf muscles.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators conduct a prospective mono-centric trial on all patient with peripheral
      arterial disease with intermittent claudication that receive supervised exercise therapy
      (SET) and additional transcutaneous electric stimulation (TES) of the calf muscle. SET
      program consists in once weekly walking training for 75 min under supervision of a
      professional trainer. Patients are encouraged to continue the training modules at home. TES
      is performed using the mobile &quot;Veinoplus arterial&quot; device (AdRem Technology, France) on a
      daily base for 60-120 min at home. Patient outcome will be compared to the retrospectively
      analyzed results of patients, that received the same SET program alone in the past.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">May 2018</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Walking distance</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement of the pain-free and absolute walking distance on a standardized constant load treadmill test</description>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Intermittent Claudication</condition>
  <condition>Peripheral Arterial Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcutaneous electrical calf muscle stimulation + supervised walking therapy</intervention_name>
    <description>transcutaneous electrical calf muscle stimulation + supervised walking therapy</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients of our department of vascular end endovascular surgery, university hospital
        Dusseldorf with the above mentioned inclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  intermittent claudication due to peripheral arterial disease

          -  ankle brachial index &lt;/=0.9

          -  occlusion or stenosis of the superficial femoral artery

        Exclusion Criteria:

          -  rest pain or peripheral arterial lesions

          -  contraindications for supervised walking therapy

          -  non-vascular conditions that limit patients´ walking ability

          -  patients that have already received supervised walking therapy

          -  occlusion of the deep femoral artery

          -  occlusion or high-grade stenoses of the iliac arteries

          -  stroke in the last 12 months

          -  premenopausal women

          -  diabetes mellitus, dialysis, sclerodermia and other conditions that impair leg
             perfusion

          -  active cilostazol therapy or alprostadil-infusion in the last 3 months

          -  pacemaker, defibrillator systems, life vest

          -  visible muscle contraction is not achieved without pain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip Düppers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Vascular and Endovascular Surgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philip Düppers, MD</last_name>
    <phone>+492118117090</phone>
    <email>philip.dueppers@med.uni-duesseldorf.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Dusseldorf, Department of Vascular and Endovascular Surgery</name>
      <address>
        <city>Dusseldorf</city>
        <state>NRW</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Düppers, MD</last_name>
      <phone>+492118117090</phone>
      <email>philip.dueppers@med.uni-duesseldorf.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2018</study_first_submitted>
  <study_first_submitted_qc>April 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2018</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Heinrich-Heine University, Duesseldorf</investigator_affiliation>
    <investigator_full_name>Dr. Philip Düppers</investigator_full_name>
    <investigator_title>Dr. med.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Intermittent Claudication</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

